The trademark application EPIPLANT was filed by Vinci Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 1, 2023, and it was registered by office on November 8, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).